Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-06

FDA Approved: LEVETIRACETAM IN SODIUM CHLORIDE — Original Application (Nexus Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a generic levetiracetam in sodium chloride (ANDA) from Nexus Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levetiracetam in Sodium Chloride (LEVETIRACETAM IN SODIUM CHLORIDE)

Snippet

ORIG AP for LEVETIRACETAM IN SODIUM CHLORIDE (LEVETIRACETAM)